PTO- 1478 |
Approved for use through 09/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97051829 |
Filing Date: 09/29/2021 |
Input Field |
Entered |
TEAS Plus | YES |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\970\518\97051829\xml1 \ FTK0002.JPG |
*SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | L, P, LABPORT |
*COLOR MARK | YES |
*COLOR(S) CLAIMED (If applicable) |
The color(s) red is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of Stylized letters L and P, and the text LABPORT. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 944 x 264 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Vivera Pharmaceuticals Inc. |
*MAILING ADDRESS | 4533 Macarthur Blvd, #5049 |
*CITY | Newport Beach |
*STATE (Required for U.S. applicants) |
California |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
92660 |
PHONE | 949-234-6161 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
*TYPE | CORPORATION |
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
*INTERNATIONAL CLASS | 044 |
*IDENTIFICATION | Medical diagnostic testing, monitoring and reporting services; Medical information; Medical information services provided via the Internet; Providing medical information; Providing medical information from a web site; Providing medical information in the field of laboratory testing; Providing medical information to patients in the form of reports in the field of laboratory testing; Provision of medical information; Provision of medical services by health care professionals via the internet or telecommunication networks; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks; Testing for medical diagnostic or treatment purposes in the field of infectious diseases |
*FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 07/01/2021 |
FIRST USE IN COMMERCE DATE | At least as early as 07/01/2021 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-26008801c813b1004112 ff1aaf95313f-202109232039 42667852_._LabPort___The_ future_of_lab_testing.pdf |
CONVERTED PDF FILE(S) (3 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\970\518\97051829\xml1\ FTK0003.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\970\518\97051829\xml1\ FTK0004.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\970\518\97051829\xml1\ FTK0005.JPG | |
SPECIMEN DESCRIPTION | web page |
WEBPAGE URL | http://labport.app/ |
WEBPAGE DATE OF ACCESS | 09/17/2021 |
ADDITIONAL STATEMENTS SECTION | |
*TRANSLATION (if applicable) |
|
*TRANSLITERATION (if applicable) |
|
*CLAIMED PRIOR REGISTRATION (if applicable) |
|
*CONSENT (NAME/LIKENESS) (if applicable) |
|
*CONCURRENT USE CLAIM (if applicable) |
|
ATTORNEY INFORMATION | |
NAME | Bruce Hare |
ATTORNEY DOCKET NUMBER | VIV-T021K-N1 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Genius Patent APC |
STREET | 2305 Historic Decatur Rd suite 100 |
CITY | San Diego |
STATE | California |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 92106 |
PHONE | 619-880-9464 |
EMAIL ADDRESS | bruce@geniuspatent.com |
CORRESPONDENCE INFORMATION | |
NAME | Bruce Hare |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | bruce@geniuspatent.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | admin@geniuspatent.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Plus |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 250 |
*TOTAL FEES DUE | 250 |
*TOTAL FEES PAID | 250 |
SIGNATURE INFORMATION | |
* SIGNATURE | /Paul Edalat/ |
* SIGNATORY'S NAME | Paul Edalat |
* SIGNATORY'S POSITION | President |
SIGNATORY'S PHONE NUMBER | 949-234-6161 |
* DATE SIGNED | 09/28/2021 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 09/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97051829 |
Filing Date: 09/29/2021 |
The applicant's current Correspondence Information: |
Bruce Hare |
PRIMARY EMAIL FOR CORRESPONDENCE: bruce@geniuspatent.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): admin@geniuspatent.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|